2016–2018 Laser-based radiocarbon detection to help drug development
Bringing a new drug to the market is a long and expensive process. To reduce the cost and improve the success rate of drug candidates, understanding of the drug pathways in the human body is crucial before starting full human trials. Radiocarbon labelling is often used in this context, as it allows following the drug in the body during the preclinical trials. However, current methods to detect radiocarbon lack either sensitivity or on-line measurement capabilities. In this project, a novel instrument for radiocarbon detection based on laser spectroscopy is currently being developed and for the first time, radiocarbon will be detected in biological samples using laser spectroscopy.
More information: Guillaume Genoud, tel. +358 50 511 0065, guillaume.genoud(at)vtt.fi